BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 1940589)

  • 1. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
    Leehey DJ; Gollapudi P; Deakin A; Reid RW
    J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
    Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP
    Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solute-free water retention in preascitic cirrhotic rats following intravenous water loading.
    Sansoe G; Aragno M; Smedile A; Rizzetto M; Rosina F
    J Physiol Pharmacol; 2009 Dec; 60(4):111-7. PubMed ID: 20065504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prostaglandin A 1 on renal and adrenal function in man.
    Fichman MP; Littenburg G; Brooker G; Horton R
    Circ Res; 1972 Sep; 31(9):Suppl 2:19-35. PubMed ID: 4341478
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostaglandin synthesis and the action of vasopressin during extracellular volume expansion in the dog.
    Kövér G; Szemerédi K; Tost H
    Acta Physiol Hung; 1983; 61(3):169-84. PubMed ID: 6650187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
    Bichet DG; Van Putten VJ; Schrier RW
    N Engl J Med; 1982 Dec; 307(25):1552-7. PubMed ID: 6755251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of renin and aldosterone in cirrhotic patients with ascites.
    Rosoff L; Zia P; Reynolds T; Horton R
    Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function test of renal excretion of water and sodium after water loading in liver cirrhosis].
    Giudici Cipriani A; Richeri F; Falchero M; Colombo P; Bertolazzi R; Folco U; Marenco G
    Minerva Med; 1983 Jun; 74(27):1629-34. PubMed ID: 6856172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute water loading on plasma levels of antidiuretic hormone AVP aldosterone, ANP fractional excretion of sodium and plasma and urine osmolalities in myxedema.
    Bai Y; Liu XM; Guo ZS; Dai WX; Shi YF; Zhou XY
    Chin Med J (Engl); 1990 Sep; 103(9):704-8. PubMed ID: 2147645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular handling of sodium and phosphate in non-ascitic liver cirrhosis.
    Caregaro L; Angeli P; Merlo A; Menon F; Rondana M; Merkel C; Gatta A
    Scand J Clin Lab Invest; 1987 May; 47(3):247-51. PubMed ID: 3589489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
    Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.